ABCB1 and lymphoma: Our results also support the hypothesis that MDR-1 may at the very least be a marker of aggressive tumors [78], as we consistently observe at least MDR-1 or BCRP protein expression in all tumors samples obtained from human breast cancer patients and canines with lymphoma that failed chemotherapy [80].